ARVN Q1 2021 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$907M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M-11.9% YoY

Gross Profit

$6M100.0% margin

Operating Income

-$42M-758.2% margin

Net Income

-$41M-745.5% margin

EPS (Diluted)

$-0.84

QoQ Revenue Growth

+148.0%

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$40M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$682M

Total Liabilities

$66M

Stockholders' Equity

$615M

Cash & Equivalents

$346M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$6M	-11.9%
Gross Profit	$6M	$6M	-11.9%
Operating Income	-$42M	-$23M	-78.1%
Net Income	-$41M	-$22M	-88.6%